Canaccord Genuity Group Forecasts Strong Price Appreciation for Waystar (NASDAQ:WAY) Stock

Waystar (NASDAQ:WAY) had its price objective lifted by research analysts at Canaccord Genuity Group from $33.00 to $34.00 in a research report issued on Tuesday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Canaccord Genuity Group‘s price target indicates a potential upside of 20.82% from the stock’s current price.

WAY has been the subject of several other reports. Wolfe Research upgraded Waystar to an “outperform” rating in a research report on Thursday, August 13th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $39.00 target price on shares of Waystar in a research report on Friday, July 31st. Wells Fargo & Company lowered their target price on Waystar from $36.00 to $33.00 and set an “overweight” rating for the company in a research note on Thursday, July 30th. UBS Group dropped their target price on shares of Waystar from $37.00 to $33.00 and set a “buy” rating for the company in a report on Thursday, July 30th. Finally, BMO Capital Markets restated an “outperform” rating on shares of Waystar in a research note on Thursday, August 27th. Two research analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $34.95.

Waystar Stock Performance

Shares of NASDAQ:WAY opened at $28.14 on Tuesday. Waystar has a 1 year low of $17.26 and a 1 year high of $37.71. The stock has a market capitalization of $5.40 billion, a price-to-earnings ratio of 40.20, a price-to-earnings-growth ratio of 1.13 and a beta of 0.18. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.85 and a quick ratio of 1.85. The company’s 50 day simple moving average is $26.23 and its 200 day simple moving average is $23.97.

Waystar (NASDAQ:WAY) last released its earnings results on Monday, November 2nd. The company reported $0.44 earnings per share for the quarter, topping the consensus estimate of $0.41 by $0.03. The firm had revenue of $325.62 million during the quarter, compared to analysts’ expectations of $323.43 million. Waystar had a return on equity of 7.03% and a net margin of 11.18%. The company’s quarterly revenue was up 21.2% on a year-over-year basis. During the same period in the prior year, the company earned $0.37 earnings per share. As a group, research analysts predict that Waystar will post 1.47 EPS for the current fiscal year.

Insider Buying and Selling

In other Waystar news, CEO Matthew Hawkins sold 82,500 shares of the business’s stock in a transaction that occurred on Tuesday, October 6th. The shares were sold at an average price of $26.23, for a total transaction of $2,163,975.00. Following the sale, the chief executive officer directly owned 1,804,794 shares of the company’s stock, valued at $47,339,746.62. The trade was a 4.37% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 247,500 shares of company stock worth $6,370,499. 3.50% of the stock is owned by company insiders.

Hedge Funds Weigh In On Waystar

Several large investors have recently modified their holdings of the business. Canada Pension Plan Investment Board acquired a new stake in Waystar in the second quarter valued at $390,593,000. BlackRock Inc. acquired a new position in Waystar during the 2nd quarter worth about $357,950,000. Advent International L.P. bought a new stake in shares of Waystar in the 2nd quarter valued at about $227,060,000. Jupiter Topco LLC bought a new stake in shares of Waystar in the 2nd quarter valued at about $58,960,000. Finally, Bank of America Corp DE bought a new stake in shares of Waystar in the 2nd quarter valued at about $53,031,000.

Trending Headlines about Waystar

Here are the key news stories impacting Waystar this week:

• Positive Sentiment: Q3 earnings and revenue beat estimates. Waystar reported non-GAAP earnings of $0.44 per share, ahead of the $0.41 consensus estimate, while revenue reached $325.6 million versus expectations of $323.4 million. EPS increased from $0.37 a year earlier. Waystar Holding Beats Q3 Earnings and Revenue Estimates
• Positive Sentiment: Strong growth and margins support the bullish reaction. Third-quarter revenue rose 21% year over year to $325.6 million. Waystar also reported $31.0 million of GAAP net income, $87.1 million of non-GAAP net income, a 10% net income margin and a 43% adjusted EBITDA margin. Waystar Reports Third Quarter 2026 Results
• Positive Sentiment: Management raised its full-year adjusted EBITDA outlook. Waystar now expects 2026 adjusted EBITDA of $543 million to $549 million, an increase that signals better-than-expected operating leverage and profitability. The company maintained a 2026 revenue forecast of $1.277 billion to $1.287 billion. Waystar Raises Adjusted EBITDA Outlook
• Neutral Sentiment: Investor focus now shifts to execution and valuation. The earnings call provided additional commentary on the quarter and outlook. With WAY trading above its 50-day and 200-day moving averages and carrying a P/E ratio around 40, continued revenue growth and delivery of the higher EBITDA target may be needed to sustain further gains. Waystar Q3 2026 Earnings Call Transcript

Waystar Company Profile

Waystar Holding Corp. is a healthcare technology company that provides cloud-based software designed to simplify administrative and financial processes across the healthcare industry. Its platform connects healthcare providers, health plans and patients, helping organizations manage revenue cycle operations and improve the flow of information and payments.

The company’s products and services include electronic claims management, eligibility and benefits verification, prior authorization, payment integrity, denial management, patient estimates and payments, billing automation, and healthcare analytics.